The holy grail of 7%
Reuters recently published a well-researched article series on America’s losing battle against diabetes. It was an interesting read, especially the second part that claims that the pharmaceutical industry is responsible for the ‘aggressive’ HbA1c targets that doctors promote amongst their patients. The target level is an HbA1c of 7% (53 mmol/mol) which corresponds to an…
Read more
Recent Comments